Roche Diagnostics Operations, Inc.

Universiteit Maastricht

Academisch Ziekenhuis Maastricht

Maastricht University

Ulrich Schotten

Johann Karl

Ursula-Henrike Wienhues-Thelen

Andre Ziegler

Roberto Latini

Vinzent Rolny

Serge Masson

Bart Maesen

Manuel Dietrich

Peter Kastner

Stef Zeemering

Disclosed is a method for assessing atrial fibrillation in a subject, said method comprising the steps of determining the amount of ESM-1 in a sample from the subject, and comparing the amount of ESM-1 to a reference amount, whereby atrial fibrillation is to be assessed. Moreover, a method for diagnosing heart failure and/or at least one structural or functional abnormality of the heart associated with heart failure is disclosed.

Circulating ESM-1 (endocan) in the assessment of atrial fibrillation and/or stroke

The invention relates to a computer-implemented method for determining an AF complexity value. The method includes applying a template matching algorithm to an ECG signal to obtain a set of candidate deflections and identifying intrinsic deflections within the set of candidate deflections. The method further includes determining a number of intrinsic deflections and a number of far-field deflections within the set of candidate deflections, based on the identified intrinsic deflections, and determining the AF complexity value as a ratio between the number of far-field deflections and the number of intrinsic deflections.

Non-invasive classification of atrial fibrillation by probabilistic interval analysis of a transesophageal electrocardiogram

Growing community of inventors

Aachen, Germany

Ulrich Schotten